Hatched three years ago, the restructuring is now expected to deliver $1 billion in new cost reductions and save Pfizer another $1.5 billion by streamlining drug production.
An article from
Dive Brief
Hatched three years ago, the restructuring is now expected to deliver $1 billion in new cost reductions and save Pfizer another $1.5 billion by streamlining drug production.
Published Aug. 4, 2026
Pfizer announced new cost cuts on Aug. 4, 2026.
Pfizer unveils additional $2.5B in planned cost savings through 2029
Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
Pfizer to make $2.5B in new cost cuts
Pfizer raises sales guidance on high demand for older drugs
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer Raises Sales Guidance on High Demand for Older Drugs
Pfizer has already made its biggest deals, Bourla says
What's Going on With Pfizer Stock Tuesday? - Pfizer (NYSE:PFE)
Pfizer will reduce its costs by $2.5 billion in another round of cutbacks which will kick in next year and run through 2029. |…
Pfizer has reported impressive second-quarter earnings, driven by the success of Eliquis and newly acquired pharmaceutical…
GENEVA: Pfizer on Tuesday reported better-than-expected second-quarter results, boosted by strong demand for blood thinner…
Pfizer’s yearslong cost-cutting effort is continuing apace, and it disclosed a $4.3 billion write-down tied to a Phase 3 trial…
The results come as Pfizer and other drugmakers grapple with Trump's calls to lower U.S. drug prices and brace for his planned…
Drugmaker plans for another $2.5bn in cost savings as it looks to move beyond post-Covid sales slump
